Ftse Mib
38.421,05
0,45%
DAX
22.287,56
-0,24%
S&P 500
6.013,13
-1,71%
NASDAQ
19.524,01
-2,20%
Bitcoin
96.214,66
-0,37%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ OptiNose Inc (OPTN) OptiNose Inc (OPTN) Notizie

OPTN

OptiNose (OPTN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OPTN
DataOraFonteTitoloSimboloCompagnia
07/02/202517:58Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:OPTNOptiNose Inc
15/01/202513:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPTNOptiNose Inc
15/01/202513:00GlobeNewswire Inc.Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 MillionNASDAQ:OPTNOptiNose Inc
26/12/202413:00GlobeNewswire Inc.Optinose Announces 1-for-15 Reverse Stock SplitNASDAQ:OPTNOptiNose Inc
18/12/202422:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
17/12/202415:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:OPTNOptiNose Inc
12/12/202416:04Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:OPTNOptiNose Inc
02/12/202422:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:OPTNOptiNose Inc
02/12/202421:53GlobeNewswire Inc.Optinose to Present at the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:OPTNOptiNose Inc
12/11/202414:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPTNOptiNose Inc
12/11/202413:00GlobeNewswire Inc.Optinose Reports Third Quarter 2024 Financial Results and Recent Operational HighlightsNASDAQ:OPTNOptiNose Inc
05/11/202422:30GlobeNewswire Inc.Optinose Announces Reporting Date for Third Quarter 2024 Financial ResultsNASDAQ:OPTNOptiNose Inc
18/10/202420:52Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:OPTNOptiNose Inc
16/10/202422:05GlobeNewswire Inc.Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OPTNOptiNose Inc
08/10/202400:39Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:OPTNOptiNose Inc
07/10/202422:59GlobeNewswire Inc.Optinose Appoints Terry Kohler as Chief Financial OfficerNASDAQ:OPTNOptiNose Inc
05/09/202415:00GlobeNewswire Inc.New Peer-Reviewed Data Highlight the Benefits of XHANCE in Chronic Rhinosinusitis Patients with or without Prior Sinus SurgeryNASDAQ:OPTNOptiNose Inc
26/08/202415:00GlobeNewswire Inc.Optinose to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:OPTNOptiNose Inc
08/08/202413:00GlobeNewswire Inc.Optinose Reports Second Quarter 2024 Financial Results and Recent Operational HighlightsNASDAQ:OPTNOptiNose Inc
02/08/202414:30GlobeNewswire Inc.Optinose Announces Reporting Date for Second Quarter 2024 Financial ResultsNASDAQ:OPTNOptiNose Inc
27/06/202413:00GlobeNewswire Inc.Expanded Access to XHANCE with Addition to National Commercial FormulariesNASDAQ:OPTNOptiNose Inc
29/05/202421:32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OPTNOptiNose Inc
20/05/202420:33Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:OPTNOptiNose Inc
17/05/202418:00GlobeNewswire Inc.Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQNASDAQ:OPTNOptiNose Inc
14/05/202413:00GlobeNewswire Inc.Optinose Reports First Quarter 2024 Financial Results and Recent Operational HighlightsNASDAQ:OPTNOptiNose Inc
10/05/202420:56GlobeNewswire Inc.Optinose Announces Reporting Date for First Quarter 2024 Financial ResultsNASDAQ:OPTNOptiNose Inc
09/05/202413:09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OPTNOptiNose Inc
09/05/202413:00GlobeNewswire Inc.Optinose Announces $55 Million Registered Direct OfferingNASDAQ:OPTNOptiNose Inc
25/04/202413:00GlobeNewswire Inc.Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 millionNASDAQ:OPTNOptiNose Inc
04/04/202422:01GlobeNewswire Inc.Optinose to Present at the Needham Virtual Healthcare ConferenceNASDAQ:OPTNOptiNose Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:OPTN

La tua Cronologia

BIT
UCG
Unicredit
BIT
STMMI
ST Microelectronics
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
LDO
Leonardo
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
CPR
Davide Campari
BIT
MONC
Moncler
BIT
RACE
Ferrari NV
BIT
PST
Poste Italiane S.p.a
BIT
BPE
Bper Banca
BIT
G
Generali
BIT
BAMI
Banco BPM
BIT
TIT
Telecom Italia
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci